C07J 1/0003
Androstane derivatives
Official title: {Androstane derivatives}
C07J1/0003 (Androstane derivatives) appears on 520 US grants and 339 published applications in this corpus.
Search patents in C07J- Granted patents
- 520
- Published applications
- 339
- Assignees
- 216
- Inventors
- 922
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 20 | 0 |
| 1978 | 23 | 0 |
| 1979 | 14 | 0 |
| 1980 | 23 | 0 |
| 1981 | 17 | 0 |
| 1982 | 23 | 0 |
| 1983 | 13 | 0 |
| 1984 | 18 | 0 |
| 1985 | 15 | 0 |
| 1986 | 9 | 0 |
| 1987 | 7 | 0 |
| 1988 | 2 | 0 |
| 1989 | 13 | 0 |
| 1990 | 16 | 0 |
| 1991 | 9 | 0 |
| 1992 | 17 | 0 |
| 1993 | 9 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 16 | 0 |
| 1997 | 18 | 0 |
| 1998 | 22 | 0 |
| 1999 | 15 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 5 |
| 2003 | 2 | 11 |
| 2004 | 6 | 16 |
| 2005 | 3 | 10 |
| 2006 | 6 | 3 |
| 2007 | 2 | 8 |
| 2008 | 3 | 18 |
| 2009 | 6 | 10 |
| 2010 | 6 | 7 |
| 2011 | 7 | 8 |
| 2012 | 5 | 10 |
| 2013 | 8 | 23 |
| 2014 | 5 | 21 |
| 2015 | 10 | 15 |
| 2016 | 10 | 12 |
| 2017 | 14 | 23 |
| 2018 | 13 | 12 |
| 2019 | 8 | 17 |
| 2020 | 6 | 16 |
| 2021 | 10 | 19 |
| 2022 | 9 | 15 |
| 2023 | 12 | 13 |
| 2024 | 5 | 15 |
| 2025 | 8 | 17 |
| 2026 | 1 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07J 1/0011Substituted in position 17 by a keto group348
- C07J 1/0018Substituted in position 17 beta, not substituted in position 17 alfa206
- C07J 1/0033Substituted in position 17 alfa and 17 beta137
- C07J 1/0007Not substituted in position 1730
- C07J 1/0014Substituted in position 17 alfa, not substituted in position 17 beta11
Recent patents
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Androstane derivatives with activity as pure or predominantly pure stimulators of SERCA2a for the treatment of heart failure23 Dec 2025US 12,503,484 B2Seismic Pharmaceuticals
- Encoded design integrated synthesis of nucleic acids, and phospholipids, and related pharmaceutical products18 Nov 2025US 12,473,247 B2
- Neuroactive steroids, compositions and uses thereof18 Nov 2025US 12,473,327 B2Sage Therapeutics, Inc.
- (17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use8 Jul 2025US 12,351,600 B2
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Preparation of deoxycholic acid16 Jul 2026US 2026/0200967 A1Crystal Pharma, S.A.U.
- Novel method for preparing testosterone derivatives by solid-phase synthesis25 Jun 2026US 2026/0174913 A1King Faisal Specialist Hospital & Research Centre
- Lymph directing prodrugs4 Jun 2026US 2026/0151489 A1Monash University
- Process for preparing (15alpha,16alpha,17beta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol (estetrol) and intermediates of said process4 Jun 2026US 2026/0152523 A1Industriale Chimica S.R.L.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- 19-Oxygenated-5.alpha.-androstanes for the enhancement of libido91US 4,071,625 ARichardson-Merrell Inc. · 1978
- Oral pharmaceutical preparation85US 4,147,783 AAkzona Incorporated · 1979
- 17-Hydroxy-steroids72US 4,898,694 A1990